SCHEMBL1008152

SCHEMBL1008152

COCCNc1nc2c(C(=O)O)cccc2o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.45
HTR3A P46098 4/20 0.44
MAPK1 P28482 1/20 0.44
HCAR3 P49019 1/20 0.40
MAPT P10636 2/20 0.40
IDO1 P14902 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
LIPG Q9Y5X9 1/20 0.39
LMNA P02545 1/20 0.38
NPC1 O15118 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KCNH3 Q9ULD8 1/20 0.37
PTGER4 P35408 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1006463 0.93 HTR3A (0.43) TOP2AHTR3AMAPK1IDO1MAOA
SCHEMBL1004894 0.90 TOP2A (0.50) TOP2AHTR3AMAPTLIPGNPC1
SCHEMBL1006044 0.83 TOP2A (0.48) TOP2AHTR3ANPC1ALDH1A1KDM4E
SCHEMBL3982633 0.83 HTR3A (0.56) TOP2AHTR3AMAPK1MAPTIDO1
SCHEMBL1003671 0.82 HTR3A (0.41) TOP2AHTR3AMAPTIDO1MAOA
Hydrochloric Acid SCHEMBL1004329 0.81 HTR3A (0.41) TOP2AHTR3AIDO1MAOAMAOB
SCHEMBL1004895 0.79 HCAR3 (0.40) HCAR3MAPTLIPGALDH1A1KDM4E
SCHEMBL27776060 0.79 KDM4E (0.48) TOP2AMAPK1MAPTALDH1A1KDM4E
SCHEMBL1005664 0.78 HTR3A (0.54) TOP2AHTR3AIDO1MAOAMAOB
SCHEMBL1006835 0.77 HTR3A (0.41) TOP2AHTR3AIDO1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
EP-2061460-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS Albany Molecular Research, Inc. (US) 2009-05-27 EP disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed
WO-2008019372-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS ALBANY MOLECULAR RESEARCH, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS HTR3E, HTR3C, HTR3A TOP2A 323/4885HTR3A 3/4885MAPK1 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.